Cetuximab (INN) is an epidermal growth factor receptor (EGFR) inhibitor used for the treatment of metastatic colorectal cancer, metastatic non-small cell lung cancer and head and neck cancer.
Cetuximab is a monoclonal antibody that inhibits the epidermal growth factor receptor (EGFR) which is present on the surface of some cancer cells. Cetuximab binds to the receptor, preventing epidermal growth factor (EGF) from binding to it and stimulating growth of th
What Erbitux Is Used For: 1  Erbitux is used to treat metastatic colorectal cancer (cancer spread beyond the colon or rectum) that over-expresses the epidermal growth factor receptor (EGFR). 2  Approved for the treatment of squamous cell carcinoma of the head and neck.
Brand Name: Erbitux Â®. Cetuximab is used to treat a certain type of head and neck cancer, and colorectal cancer. More specifically, cetuximab may be used alone or in combination with another medication to treat a certain type of colon or rectum cancer that has spread to other parts of the body.
Cetuximab is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. Cetuximab is used to treat cancers of the colon and rectum. It is also used to treat head and neck cancer. Cetuximab is often used in combination with other cancer medications. Cetuximab may also be used for purposes not listed in this medication guide. Cetuximab is often used in combination with other cancer medications and/or radiation treatments.